Flu tests from R-Biopharm also detect new virus variants
more
Stories from Darmstadt
Gerresheimer and Merck Transform Primary Packaging into Digital Twins
Düsseldorf (ots) - Gerresheimer AG, a leading provider of healthcare solutions and drug delivery systems for pharma, biotech and cosmeticsand Merck, Darmstadt, a leading science and technology company, jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain. The proof of concept aims to ...
morebenfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT)
Darmstadt (ots) - benfovir AG, a German pharmaceutical company focused on developing small molecules against viral infections such as SARS-CoV-2, dengue and herpes virus, today announced that the first part of the Phase 1 clinical trial (BV-01-101/ EudraCT Number: 2021-005616-60.) designed to evaluate the safety, ...
moreFraunhofer-Institut für Sichere Informationstechnologie SIT
Document protection with colorful barcode / Simple forgery protection for paper documents and PDFs – automated tamper control via app
moreFraunhofer-Institut für Sichere Informationstechnologie SIT
Mechanism for Internet security broken
more- 5
Press Release - hubergroup Print Solutions relaunches UV flexo portfolio under the iray brand®
One documentmore SIGMA-ALDRICH AND GENOWAY EXPAND THEIR CRISPR/CAS9 STRATEGIC ALLIANCE
ST. Louis, Mo. and Lyon, France (ots/PRNewswire) - Sigma-Aldrich Co LLC (a subsidiary of Merck KGaA, Darmstadt, Germany), a leading science and technology company and provider of genome editing research tools, and genOway the leading company in the preclinical research model space, today announced a new structure to their 2018 strategic alliance in the CRISPR/Cas9 ...
moreR-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
moreR-Biopharm is IVDR certified
more- 2
Schoeller Allibert appoints Oliver Iltisberger as CEO
more benfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS
Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...
more- 2
R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics
more R-Biopharm announces test to detect monkeypox virus
moreDEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES
more- 2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation
more German Research Offers Innovative Solutions to World’s Most Pressing Issues
Berlin (ots) - Germany renowned Fraunhofer Institutes have come up with novel approaches to everything from supply chains to digital medical care to agriculture. Europe’s largest economy is buoyed by an extraordinary number of extra-university research centers, as recent developments at one of the most prominent institutions – the Fraunhofer Society – show. There ...
moreDeutsche Bundesstiftung Umwelt (DBU)
Steinmeier: Let us change course for climate protection and biodiversity / Federal President presents German Environmental Prize
Osnabrück/Darmstadt (ots) - With an appeal to our sense of solidarity as a global community, today (Sunday), at the darmstadtium conference centre in Darmstadt, Germany’s Federal President Frank-Walter Steinmeier called for a change of course to conserve biodiversity and stop global warming. At the awards ...
moreDeutsche Bundesstiftung Umwelt (DBU)
“The award recipients give us hope” / Ecologist and peatland researcher receive German Environmental Prize
Osnabrück/Darmstadt (ots) - Today (Sunday) in Darmstadt, the German Federal Environmental Foundation (DBU) honoured exceptional efforts in the fight against climate change and to protect biodiversity with one of Europe’s most prestigious and highly endowed environmental awards. German President Frank-Walter ...
moreFraunhofer-Institut für Sichere Informationstechnologie SIT
Study: IT security for electric cars in China
more- 2
Reliable climate protection with Passive House
more Get a glimpse of the near and distant future of additive manufacturing
One documentmoreMerck and BioMed X Institute Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity
Darmstadt, Germany (ots/PRNewswire) - - Merck to support up to six additional research projects at the BioMed X Institute in Heidelberg within the next six years - Call for application for a global crowdsourcing project, 'Regulatory T Cell Dysfunction in Autoimmunity and Inflammaging' Merck, a leading science and ...
moreLand use in the EU Climate Target Plan 2030: Ecosystems are more than carbon reservoirs
The management of forests, cropland and grassland impacts on the amount of greenhouse gases in the atmosphere. These activities must therefore be taken into account in the EU's Climate Target Plan. The EU Parliament and the European Council are currently arguing about the "how". The outcome of this ...
One documentmoreMerck Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer
Darmstadt, Germany (ots/PRNewswire) - Not intended for US-, Canada- or UK-based media Merck, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of patients with locally advanced or ...
more- 3
Press Release - Extended production possibilities: hubergroup presents LED UV inks for newspaper presses
One documentmore New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLAD®-treated RMS Patients Mount Protective Antibody Response to Common Vaccines
Darmstadt, Germany (ots/PRNewswire) - MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing Initial findings from the CLOCK-MS vaccine ...
moreFurther design of EU climate target for 2030 decisive for climate protection
Press release Freiburg/Berlin, 11 December 2020 Further design of EU climate target for 2030 decisive for climate protection Just in time for the fifth anniversary of the Paris Climate Change Agreement, the European Council has decided to tighten the EU's climate targets. By 2030, the EU is to reduce ...
One documentmoreEuropean Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations
Darmstadt, Germany (ots/PRNewswire) - Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial ...
moreMerck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up to EUR 605 million in development ...
moreMerck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis
Darmstadt, Germany (ots/PRNewswire) - - Merck out-licenses promising clinical-stage program to Novartis - Anti-ADAMTS5 Nanobody® programis Phase II-ready with novel MoA which could protect against cartilage damage and reduce joint pain - Merck receives upfront payment of EUR 50 million with the potential of ...
more
12345678Next